Immunomodulatory role of plasmacytoid dendritic cells in multiple sclerosis

2012 Pilot Project Read More

Investigators

Principal Investigator: Laura Piccio, MD, PhD (WUSTL Neurology)
Co-Investigator: Marina Cella, MD (WUSTL Pathology & Immunology)

Description

Multiple sclerosis (MS) is a highly debilitating disease of the central nervous system that affects millions of people worldwide. In MS patients, immune cells (that normally fight viruses and bacteria) are attacking components of their own body in the central nervous system. This “autoimmune” attack is believed to be mainly orchestrated by white blood cells called lymphocytes, a specific type of immune cells. Lymphocyte auto-reactive responses can be counter-regulated by other immune cells, including some white blood cells called plasmacytoid dendritic cells (PDCs). Our preliminary data show that PDCs exert a protective role in an animal model of MS. The aim of this project is to determine whether and how PDCs in MS patients lose their protective affect. Our studies will indicate if selective manipulation of this cell type could be suitable to ameliorate or cure MS.


Updated 11/19/2012

EmailPrintShare

Hope Center Investigators

Laura Piccio

Support

This pilot project is made possible by the Danforth Foundation Challenge.

Danforth Challenge